Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 04, 2026
Liquid Biopsy Cancer Testing Is The Next Big Investment Opportunity
09:25am, Tuesday, 17'th Nov 2020
Multiple companies are working on next-gen blood biopsies tech to detect cancer. The potential market size is big according to most estimates and analysts.
Forget Apple! Buy These 2 High-Growth Stocks Instead
08:08am, Saturday, 14'th Nov 2020
Instead of investing in the company that would have made you a millionaire years ago, seek out the ones that have the potential from here.
Stocks Rally To Cap Wild Week: Nio, Zoom Video Flash Sell Signals; Exact Sciences Trades Bullishly
04:18pm, Friday, 13'th Nov 2020
Stocks rally to cap wild week: Nio, Zoom Video flash sell signals; Exact Sciences trades bullishly. Investor's Business Daily has been helping people invest smarter results by providing exclusive stoc
Here's Why Exact Sciences Jumped 21.5% in October
09:06pm, Sunday, 08'th Nov 2020
A solid third quarter plus an acquisition to drive future growth has investors giddy.
Exact Sciences to participate in November investor conferences
06:00am, Monday, 02'nd Nov 2020
MADISON, Wis., Nov. 2, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors to participa
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q3 2020 Results - Earnings Call Transcript
12:13am, Friday, 30'th Oct 2020
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q3 2020 Results - Earnings Call Transcript
Exact Sciences Commends Task Force for Draft Updated Guidelines that include Colorectal Cancer Screening Beginning at Age 45
04:35pm, Tuesday, 27'th Oct 2020
MADISON, Wis., Oct. 27, 2020 /PRNewswire/ -- The United States Preventive Services Task Force (USPSTF) today released draft updated colorectal cancer screening guidelines recommending that screening b
Exact Sciences soars 33% after agreeing to acquire early cancer detection firm for $2.15 billion (EXAS)
04:05pm, Tuesday, 27'th Oct 2020
Exact Sciences soared as much as 33% on Tuesday to record highs after the diagnostics company said it would acquire Thrive Earlier Detection for up to $2.15 billion in a stock and cash deal. Thrive Ea
Here's Why Exact Sciences Stock Rocketed Higher Today
02:09pm, Tuesday, 27'th Oct 2020
Solid earnings and a smart acquisition have investors hitting the buy button.
Exact Sciences Rallies On 2 M&A Deals In Cancer Screening Market
12:38pm, Tuesday, 27'th Oct 2020
Shares of cancer screening and diagnostics company EXACT Sciences Corporation (NASDAQ: EXAS) were rallying to a record high Tuesday after it announced two M&A transactions and third-quarter results.
Exact Sciences News: Why EXAS Stock Is Shooting 18% Higher Today
11:52am, Tuesday, 27'th Oct 2020
Exact Sciences (EXAS) stock was flying high on Tuesday following a flurry of news from the molecular diagnostics company. The post Exact Sciences News: Why EXAS Stock Is Shooting 18% Higher Today appe
Exact Sciences to acquire Thrive Earlier Detection Corp. in cash and stock deal worth up to $2.15 billion
07:15am, Tuesday, 27'th Oct 2020
Exact Sciences Corp. said Tuesday it has agreed to acquire Thrive Earlier Detection Corp. in a cash and stock deal worth up to $2.15 billion. Thrive Earlier is a health care company that aims to bring
Exact Sciences Announces Entry into Agreements to Sell $869 Million of Common Stock in Registered Direct Offering
07:10am, Tuesday, 27'th Oct 2020
MADISON, Wis., Oct. 27, 2020 /PRNewswire/ -- Exact Sciences Corporation (Nasdaq: EXAS) today announced the entry into agreements to sell an aggregate of 8,605,483 shares (the "Shares") of its common s
Exact Sciences Announces Third Quarter 2020 Results
07:01am, Tuesday, 27'th Oct 2020
MADISON, Wis., Oct. 27, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $408.4 million for the third quarter ended September 30, 2020, co
Was The Smart Money Right About Crowding Into EXACT Sciences Corporation (EXAS)?
09:01pm, Monday, 26'th Oct 2020
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions
